Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.09
-0.41 (-7.45%)
At close: May 15, 2026, 4:00 PM EDT
5.10
+0.01 (0.20%)
After-hours: May 15, 2026, 7:25 PM EDT
Lexeo Therapeutics Employees
Lexeo Therapeutics had 59 employees as of December 31, 2025. The number of employees decreased by 13 or -18.06% compared to the previous year.
Employees
59
Change
-13
Growth
-18.06%
Revenue / Employee
n/a
Profits / Employee
-$1,483,068
Market Cap
399.68M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 59 | -13 | -18.06% |
| Sep 30, 2025 | 61 | -11 | -15.28% |
| Jun 30, 2025 | 61 | -8 | -11.59% |
| Mar 31, 2025 | 75 | 17 | 29.31% |
| Dec 31, 2024 | 72 | 14 | 24.14% |
| Sep 30, 2024 | 72 | 14 | 24.14% |
| Jun 30, 2024 | 69 | - | - |
| Dec 31, 2023 | 58 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Replimune Group | 479 |
| Lyell Immunopharma | 300 |
| ADC Therapeutics | 193 |
| Verastem | 102 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| PureTech Health | 56 |
LXEO News
- 5 days ago - Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c) - TheFly
- 6 days ago - Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights - GlobeNewsWire
- 18 days ago - Lexeo Therapeutics management to meet with Cantor Fitzgerald - TheFly
- 19 days ago - Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Lexeo Therapeutics reports Q4 EPS (27c), consensus (30c) - TheFly
- 6 weeks ago - Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 2 months ago - Lexeo Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire